.jpg)
In recent years, the use of weight-loss medications has gained significant traction, especially with the rise of GLP-1 receptor agonists like Wegovy. As more people explore this option for managing weight, questions around its safety—especially for expecting or nursing mothers—have become increasingly common. If you're considering Wegovy in Dubai and are currently pregnant, planning to become pregnant, or breastfeeding, it's essential to understand how this medication might impact your health and your baby’s well-being.
Wegovy (semaglutide) is an FDA-approved medication originally developed for type 2 diabetes but later found effective in managing chronic weight issues. It works by mimicking a hormone called GLP-1 that helps regulate appetite and food intake, often leading to significant weight loss when combined with a healthy diet and exercise.
The short answer? No, Wegovy is not recommended during pregnancy.
Clinical guidelines and available data suggest that there isn’t enough evidence to support the safe use of Wegovy during pregnancy. Animal studies have shown potential risks to the fetus, including birth defects and pregnancy loss, which has raised red flags about its use in human pregnancies.
If you’re currently using Wegovy and discover you're pregnant, it’s generally advised to stop the medication immediately. The potential risks to fetal development outweigh any benefits Wegovy might offer during this time.
The story isn’t much different when it comes to breastfeeding. Since semaglutide is a relatively new medication, studies on its presence in human breast milk and its effects on a nursing infant are still lacking. Without clear data, the safety of Wegovy during breastfeeding cannot be assured.
Health experts recommend erring on the side of caution and avoiding Wegovy while nursing. The body goes through significant hormonal changes during this period, and introducing a weight-loss drug may affect both the mother’s milk supply and the baby’s growth or digestion.
Timing is everything when it comes to weight-loss medications and reproductive health. If you’re planning to become pregnant, it’s a good idea to discontinue Wegovy at least two months prior, as semaglutide has a long half-life and can remain in your system for several weeks. This window helps reduce any possible risks to early fetal development.
While Wegovy Dubai is a powerful tool for weight loss, it’s not the only option—and certainly not the best choice during pregnancy or breastfeeding. Instead, focus on: